Patanajali Ayurved, the FMCG major led by yoga guru Ramdev has been ordered by authorities in Nepal to recall six ayurvedic medicines after the products failed microbial tests. The Ministry of Health’s Department of Drug Administration, cited “substandard quality” as it’s six products failed quality checks at the laboratory in Nepal and was declared unsafe for human consumption.
The Hindustan times reported: The six medicines includes Patanjali Divya Gashar churna, Bahuchi churna, Amla churna, Triphala churna, Adviya churna and Aswangandha .
There were total of 7 products for the test out of which 6 failed the microbial lab test. The report further stated that between 2013 and 2016 82 samples were collected , out of which 32 failed in quality test.
“The batch of medicine which were inspected by the department are found to have contained pathogenic bacteria,” an official of the Department told PTI.
The Nepalese Drug administration authorities have urged the stake holders by public notice not to sell or prescribe the use of these six medicines with immediate effect.
Another Indian medicine, Bactoclav, produced by Micro Lab Limited of Bengaluru, also failed to meet official standards. Bactoclav, medicines produced by Micro Lab Limited of Bengaluru, had also failed to meet standards.
RTI queries in India had revealed that nearly 40% of Ayurveda products, including items from Patanjali, were found to be of substandard quality by Haridwar’s Ayurveda and Unani Office.
Earlier in May 2017, Patanjali’s Divya Amla juice and shivlingi beej had failed to meet quality standards as products was found to have less pH value than the prescribed limit.